Masimo Corp Files Definitive Additional Proxy Materials

Ticker: MASI · Form: DEFA14A · Filed: Aug 26, 2024 · CIK: 937556

Masimo CORP DEFA14A Filing Summary
FieldDetail
CompanyMasimo CORP (MASI)
Form TypeDEFA14A
Filed DateAug 26, 2024
Risk Levellow
Pages12
Reading Time14 min
Key Dollar Amounts$1.74, $1, $3.80, $4.00, $8
Sentimentneutral

Sentiment: neutral

Topics: proxy-filing, sec-filing, corporate-governance

Related Tickers: MASI

TL;DR

MASI filed more proxy docs, no fee. Shareholders get updated info.

AI Summary

Masimo Corporation filed definitive additional materials on August 26, 2024, related to its proxy statement. The filing concerns the company's Schedule 14A information, indicating it's a definitive proxy statement. No filing fee was required for this submission.

Why It Matters

This filing provides updated or supplementary information to shareholders regarding matters to be voted on at a company meeting, ensuring transparency and informed decision-making.

Risk Assessment

Risk Level: low — This filing is routine administrative material for a proxy statement and does not contain new financial or strategic information that would typically impact risk.

Key Players & Entities

FAQ

What type of filing is this for Masimo Corporation?

This is a Definitive Additional Materials filing (DEFA14A) for Masimo Corporation, serving as a supplement to their proxy statement.

When was this filing submitted to the SEC?

The filing was submitted on August 26, 2024.

Is there a filing fee associated with this document?

No, the filing indicates that no fee was required for this submission.

What is the standard industrial classification for Masimo Corporation?

Masimo Corporation's standard industrial classification is ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845].

What is the business address of Masimo Corporation?

The business address for Masimo Corporation is 52 Discovery, Irvine, CA 92618.

Filing Stats: 3,556 words · 14 min read · ~12 pages · Grade level 13.5 · Accepted 2024-08-26 11:19:43

Key Financial Figures

Filing Documents

Forward-Looking Statements

Forward-Looking Statements This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Masimo and the potential stockholder approval of the Board’s nominees; Masimo’s earnings per share estimates and targets; Masimo’s expectations to double earnings within five years; Masimo’s operating margin targets and potential growth; the proposed separation of Masimo’s consumer business, including any potential joint venture or any other potential separation of Masimo’s consumer business, the status of ongoing discussions between Masimo and other potential joint venture partners or acquirors of its consumer business, and the potential timing and structure of any separation and the expectation that the proposed separation will maximize stockholder value or be the best path for success. These forward-looking statements are based on current expectations about future events affecting Masimo and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond Masimo’s control and could cause its actual results to differ materially and adversely from those expressed in its forward-looking by Politan in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (ii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iii) factors discussed in the “Risk Factors” section of M

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing